Cryptococcus neoformans-Cryptococcus gattii species complex: An international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole

A. Espinel-Ingroff, A. I. Aller, E. Canton, L. R. Castañón-Olivares, A. Chowdhary, S. Cordoba, M. Cuenca-Estrella, A. Fothergill, J. Fuller, N. Govender, F. Hagen, M. T. Illnait-Zaragozi, E. Johnson, S. Kidd, C. Lass-Flörl, S. R. Lockhart, M. A. Martins, J. F. Meis, M. S.C. Melhem, L. Ostrosky-ZeichnerT. Pelaez, M. A. Pfaller, W. A. Schell, G. St-Germain, L. Trilles, J. Turnidge

Research output: Contribution to journalArticlepeer-review

158 Scopus citations

Fingerprint Dive into the research topics of 'Cryptococcus neoformans-Cryptococcus gattii species complex: An international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole'. Together they form a unique fingerprint.

Medicine & Life Sciences